<?xml version="1.0" encoding="UTF-8"?>

<rootTag>
  <Award>
    <AwardTitle>SBIR Phase I: Novel and Enhanced Urine Test for the Detection of The Fungal Infection Aspergillosis</AwardTitle>
    <AwardEffectiveDate>07/01/2015</AwardEffectiveDate>
    <AwardExpirationDate>12/31/2016</AwardExpirationDate>
    <AwardAmount>174999</AwardAmount>
    <AwardInstrument>
      <Value>Standard Grant</Value>
    </AwardInstrument>
    <Organization>
      <Code>07070000</Code>
      <Directorate>
        <LongName>Directorate For Engineering</LongName>
      </Directorate>
      <Division>
        <LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
      </Division>
    </Organization>
    <ProgramOfficer>
      <SignBlockName>Jesus Soriano Molla</SignBlockName>
    </ProgramOfficer>
    <AbstractNarration>The broader commercial potential of this Small Business Innovation Research (SBIR) Phase I project is for the early detection of aspergillosis, a severe fungal infection that most frequently involves the lungs in immune compromised individuals, typically as a result of cancer chemotherapy or transplantation. The disease is often misdiagnosed resulting in poor patient outcomes and death. Early detection is important to initiate therapy and save lives. &lt;br/&gt;&lt;br/&gt;The proposed project has two objectives: 1. To reconfigure a non-competitive immunoassay lateral flow device and 2. To develop novel antibodies that will result in feasibility studies of a point of care device for the detection of Asgergillus in urine. Successful completion of this project will result in a Phase II project toward commercialization.</AbstractNarration>
    <MinAmdLetterDate>06/26/2015</MinAmdLetterDate>
    <MaxAmdLetterDate>12/14/2015</MaxAmdLetterDate>
    <ARRAAmount/>
    <AwardID>1519946</AwardID>
    <Investigator>
      <FirstName>MaryAnn</FirstName>
      <LastName>Shallcross</LastName>
      <EmailAddress>maryann.shallcross@gmail.com</EmailAddress>
      <StartDate>06/26/2015</StartDate>
      <EndDate/>
      <RoleCode>Principal Investigator</RoleCode>
    </Investigator>
    <Institution>
      <Name>MycoMed Technologies</Name>
      <CityName>Baltimore</CityName>
      <ZipCode>212273831</ZipCode>
      <PhoneNumber>7038516757</PhoneNumber>
      <StreetAddress>1450 S Rolling Road</StreetAddress>
      <CountryName>United States</CountryName>
      <StateName>Maryland</StateName>
      <StateCode>MD</StateCode>
    </Institution>
    <ProgramElement>
      <Code>5371</Code>
      <Text>SMALL BUSINESS PHASE I</Text>
    </ProgramElement>
    <ProgramReference>
      <Code>5371</Code>
      <Text>SMALL BUSINESS PHASE I</Text>
    </ProgramReference>
    <ProgramReference>
      <Code>7236</Code>
      <Text>BIOPHOTONICS, IMAGING &amp;SENSING</Text>
    </ProgramReference>
    <ProgramReference>
      <Code>7909</Code>
      <Text>BIOSENSING</Text>
    </ProgramReference>
    <ProgramReference>
      <Code>8038</Code>
      <Text>Biotechnology</Text>
    </ProgramReference>
    <ProgramReference>
      <Code>8042</Code>
      <Text>Health and Safety</Text>
    </ProgramReference>
  </Award>
</rootTag>
